• Explore /
  • Poster
  • / A randomized phase III trial comparing two dose-dense, dose-intensified approaches (EPC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto).

A randomized phase III trial comparing two dose-dense, dose-intensified approaches (EPC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto).

Abstract Poster

Authors

null

Andreas Schneeweiss

Heidelberg University, Heidelberg, Germany

Andreas Schneeweiss , Volker Moebus , Jens Uwe Blohmer , Serban Dan Costa , Carsten Denkert , Holger Eidtmann , Claus Hanusch , Joern Hilfrich , Jens Bodo Huober , Christian Jackisch , Stefan Paepke , Sherko Kümmel , Hans Tesch , Michael Untch , Sibylle Loibl , Gunter Von Minckwitz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Clinical Trial Registration Number

NCT02125344

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS1101)

DOI

10.1200/jco.2015.33.15_suppl.tps1101

Abstract #

TPS1101

Poster Bd #

214b

Abstract Disclosures

Similar Posters

First Author: Esther Pohl-Rescigno

First Author: Volker Moebus

First Author: Kay T Yeung

First Author: Sayeh Moazami Lavasani